EUVIMEDEUVIMED entdecken
Crossref

Beyond prescribing rights: designing equitable and sustainable attentiondeficit/ hyperactivity disorder care pathways in Aotearoa New Zealand

Steven Lillis, Lara Oertly, Belinda Wheaton, Byron Rangiwai, Nicholas Bowden, Stephanie D'Souza

New Zealand Medical Journal · 2026

DOI: 10.26635/6965.7381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Zealand Medical Journal, 2026. Verfasst von Steven Lillis und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Waikato. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Drug Prescriptions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

aim: From February 2026, vocationally trained general practitioners and nurse practitioners in Aotearoa New Zealand are authorised to initiate stimulant medication for adults with attention-deficit/hyperactivity disorder (ADHD), marking a shift from a predominantly secondary care model. This viewpoint article examines the clinical, ethical and service-level implications of this regulatory change, with particular attention to equity, diagnostic quality, cost and sustainability in primary care. methods: This viewpoint draws on Aotearoa New Zealand policy documents, international clinical guidance and selected peerreviewed literature to inform a policy and equity-focussed analysis of expanded stimulant prescribing authority. results: The policy change has the potential to improve access to ADHD treatment; however, the absence of mandated training, competency standards or operational guidance raises concerns about diagnostic quality, management of comorbidity and prescribing safety. The time-intensive nature of adult ADHD assessment presents workload and resourcing challenges for primary care, and multiple service delivery models are likely to emerge with variable equity implications. conclusion: Expanded prescribing authority may improve access, but without appropriate training, resourcing and implementation frameworks, benefits may be unevenly realised. Clear standards and equity-centred service design are essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsDrug PrescriptionsHumansNew ZealandPrimary Health CareHealth Services Accessibility

Substanzen

Central Nervous System Stimulants

Autor:innen und Institutionen

  • University of Waikato.
  • University of Otago.
  • Unitec Institute of Technology.
  • The University of Auckland.

Zitieren

APA

Lillis, S., Oertly, L., Wheaton, B., Rangiwai, B., Bowden, N., & D'Souza, S. (2026). Beyond prescribing rights: designing equitable and sustainable attentiondeficit/ hyperactivity disorder care pathways in Aotearoa New Zealand. New Zealand Medical Journal. https://doi.org/10.26635/6965.7381

Vancouver

Lillis S, Oertly L, Wheaton B, Rangiwai B, Bowden N, D'Souza S. Beyond prescribing rights: designing equitable and sustainable attentiondeficit/ hyperactivity disorder care pathways in Aotearoa New Zealand. New Zealand Medical Journal. 2026. doi:10.26635/6965.7381

BibTeX
@article{Lillis2026,
  author = {Lillis, Steven and Oertly, Lara and Wheaton, Belinda and Rangiwai, Byron and Bowden, Nicholas and D'Souza, Stephanie},
  title = {Beyond prescribing rights: designing equitable and sustainable attentiondeficit/ hyperactivity disorder care pathways in Aotearoa New Zealand},
  journal = {New Zealand Medical Journal},
  year = {2026},
  doi = {10.26635/6965.7381}
}
Kostenlos starten →